Vascular RhoJ is an effective and selective target for tumor angiogenesis and vascular disruption.
Kim C, Yang H, Fukushima Y, Saw PE, Lee J, Park JS, Park I, Jung J, Kataoka H, Lee D, Heo WD, Kim I, Jon S, Adams RH, Nishikawa S, Uemura A, Koh GY.
Kim C, et al. Among authors: kataoka h.
Cancer Cell. 2014 Jan 13;25(1):102-17. doi: 10.1016/j.ccr.2013.12.010.
Cancer Cell. 2014.
PMID: 24434213
Free article.